Non-Surgical Cataract Reversal in a Drop!                Mal
  Why is Dr. Babizhayevs' N-Acetylcarnosine eye drop the only one that actually works?- click here
    

  Initial Results in only 3 months time.. Testimonials!

  ..Optimal Results within 6 - 12 months!

  For Pets with Cataracts Too! - click here

Special 4 Box Offer - Only $39.75 each! - Order Here!

(Can-C™) Proven in Clinical Trials to Safely Reverse Cataracts! "Patients instilled 2 drops into each eye 3 to 4 times a day, for a period of 6 months. The results showed a pronounced effect on cataracts; the effective rate was 100%, setting an unprecedented benchmark for the treatment and reversal of cataracts and other eye disorders.."

We supply Dr. Mark Babizhayevs' patented 1% NAC eye-drop under it's original name Can-C™. To date, Dr. Babizhayevs' N-Acetylcarnosine eye drop is the only cataract eye drop that has been proven in controlled clinical trials to be effective in the treatment of cataracts and safe for long term use.

Over the last decade this, non-invasive, anti-oxidant, eye drop, patented by Innovative Vision Products has generated thousands of reports of safe and effective Cataract Reversal. Can-C™ Testimonials

The statistics in the human trials show that Can-C™ Eye Drops applied for 6-months, (twice daily into the eye), in patients suffering from senile cataract, had the following results:

• 90% had an improvement in visual acuity.

• 88.9% had an improvement of glare sensitivity.

• 41.5% had an improvement of the transmissivity of the lens.

Be Sure to Look for the following statement on any box you purchase to be sure you are purchasing Dr. Babizhayevs' patent protected formula. - "Approved by Innovative Vision Products.."      For more information click here

--10-15-06 "I used Can-C™ eye drops for 4-months with amazing results.   My vision in my left eye improved from 20/40 to 20/25 and upon renewal of my driving license, the eye glass restriction was eliminated!" -Richard Lippman, MD More Testimonials!

Important Reading..

There are no more doubts regarding the effectiveness of this miraculous eye repair in a drop that originated from years of Russian research. Clinical Publications

--06-02-07 "I can tell you that the results have been amazing because my chronic Dry Eye condition is virtually non- existent as a result of using this effective product.." Norma G. Nashwauk, MN

Although the information is not yet published, this unique "IVP" N-acetylcarnosine (Can-C™) formula with its synergistic lubricants, is showing beneficial results for the following eye-disorders.

• Intraocular pressure associated with glaucoma.
• Contact lens disorders.
• Presbyopia
• Corneal disorders.
• Chronic eyestrain.
• Computer vision syndrome.
• Ocular inflammation.
• Blurred vision.
• Dry eye syndrome.
• Retinal disease
• Vitreous opacities and lesions.

Not only do the lubricants in the Can-C N-acetylcarnosine eye-drop help to make wearing contact lenses more comfortable, but n-acetylcarnosine is also believed to reduce the build up of lactic acid in the eye, thus enabling the lens to be left safely in the eye for longer.

Manufactured to cGMP pharmaceutical standards, Can-C™ has a wealth of anti-oxidant properties which can improve the overall function of the aging eye. Can-C Ingredients

Big Savings on your Shipping too! Our low flat rate shipping charge stays the same whether you purchase 1 box or 12 boxes.

Disclaimer: The Food and Drug Administration have not evaluated the statements contained herein. This product is not intended to diagnose, treat, cure or prevent any disease.

*OUR REFUND POLICY* Simply return any unused portion along with your comments. We will promptly provide a refund for any unopened vials no questions asked. (Less Shipping and a 15% Restocking Fee)

______________________________________________________________________________________________

Human Clinical Trials

In a Russian clinical trial Carnosine eye-drops were used to treat 96 patients aged 60 and above. All the patients had senile cataract in various degrees of maturity. The duration of the disease in these patients ranged between 2 and 21 years. The patients instilled 1 or 2 drops into each eye 3 or 4 times a day, for a period of 3 to 6 months. The results showed that there was a pronounced effect on senile cataract, the rate was 100% (i.e. all patients experienced an improvement). For the more mature senile cataract the effective rate was still an extremely impressive 80%. Importantly, it was also noted that there were no side effects in any of the cases. Clinical Publications

A second clinical study was designed to document and quantify the changes in lens clarity over a 6 to 24 month period. The average age of the participants was 65 and all suffered from senile cataract of a minimal to an advanced opacification. The patients received either a 1% solution of N-acetylcarnosine eye-drops or a placebo as 2-drops twice a day into each eye. The results at 6 months were impressive; 88.9% of all eyes treated with N-acetylcarnosine had an improvement of glare sensitivity. Furthermore, 90% of the eyes treated with N-acetylcarnosine showed an improvement in visual acuity. In contrast, there was little change in the eye quality of the placebo group at 6 months and the placebo group also experienced a gradual deterioration at 12 to 24 months.

Another study evaluated patients who had various degrees of eyesight impairment but who did not have the symptoms of cataract. After a course of treatment ranging from 2 to 6 months the conclusion was that the eye-drops alleviated eye tiredness and continued to improve eyesight (i.e. there was more clear vision). This is an indicator that the eye-drops have a value both for preventative purposes as well as medical applications.Clinical Publications

Animal Clinical Trials

The testing of various anti-glycation agents over nearly a decade led a Russian research team to the development of n-alpha-acetylcarnosine as a delivery system for the natural eye anti-oxidant of L-carnosine. Once laboratory testing was passed, the next stage began to test the n-acetylcarnosine eye-drops in the eyes of animals, (specifically canines and rabbits). These studies produced remarkably fast results in the improvement of clarity, glare sensitivity and overall vision for the animals involved. Furthermore, no serious side effects were noted and the beneficial affects were sustainable. Unsurprisingly, these positive results in animals led to the studies being continued in humans. Can-C™ is for Pets Too!

          ..Initial Results in only 3 months time!      

Optimal results within 6 - 12   months!           

Special Discount Offer! -  Order here!

1. Block, W. N-Acetylcarnosine may help with cataracts. NAC eye drops show benefits in both preventing and treating this age-related condition. LE Magazine, Aug. 2003.

2. Bourassa, D., and Dean, W. M.D. Carnosine: ARemarkable Multipurpose Anti-Aging Nutrient. Vitamin Research News, Vol. 14., Num. 11, Nov. 2000.

3. Babizhayev MA, Deyev A. Free radical oxidation of lipid and thiol groups in genesis of cataract. Biophysics (biofizika),1986, 31, 119-125, Pergamon Journals Ltd.

4. Babizhayev MA, Deyev Al, Linberg LF. Lipid peroxidation as a possible cause of cataract. Mech. Ageing Dev. 1988, 44, 69-89.

5. Babizhayev MA, Antioxidant activity of L-carnosine, a natural histidine-containing di-peptide in crystalline lens. Biochem. Biophys. Acta., 1989a, 1004, 363-371.

6. Babizhayev MA, Deyev A. Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal disease. Biochim. Biophys. Acta., 1989b, 1004, 124-133.

7. Maichuk, IUF, Formaziuk, VE, Sergienko, VI. Development of carnosine eyedrops and assessing their efficacy in corneal diseases. Vestn Oftalmol, 1997, 113(6): 27-31.

8. Yuneva, M.O., Bulygina, E.R., Gallant, S.C., et al. Effect of carnosine on age-induced changes in senescence-accelerated mice. J Anti-Aging Medicine, 2: 1999, 337-342.

9. Wang AM, Ma C, Xie H, and Shen, F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry, 2000, 65(7), 869-871.

10. Baslow, MH. Function of the N-acetyl-L-histidine system in the vertebrate eye. Evidence in support of a role as a molecular water pump. J Mol Neurosci, 1998, 10(3), 193-208.

11. Ermakova, V.N., Babizhaev, M.A., Bunin, A.Ya. Effect of L-carnosine on intraocular pressure. Byull. Eksp. Biol. Med. 1988, 105(4), 451-453.

12. Borioni, D., and Scassellati-Sforzolini, G. The action of paminobenzoic cid, histidine, and cortisone on the success of corneal transplants, Am J Ophthalmol, 1953, 36: 575-576.

13. Babizhayev MA, Yermakova VN, Sakina NL, Evstigneeva RP, Rozhkova EA, Zheltukhina GA. N-Acetylcarnosine is a prodrug of L-carnosine in ophthalmic application as antioxidant. Clin. Chim. Acta., 1996, 254, 1-21.

14. Babizhayev MA, Yermakova VN, Deyev Al, Seguin M-C. Imidazole-containing peptiomimetic NAC as a potent drug for the medicinal treatment of age-related cataract in humans. J. Anti-Aging Medicine 2000a, 2, 43-62.

15. Babizhayev MA, Yermakova VN, Semiletov yu A, Deyev

A. The natural histidine-containing di-peptide N-acetylcarnosine as an antioxidant for ophthalmic use. Biochemistry(Moscow), 2000b, 65, 588-598.

16. Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Kurysheva NI, Zhokotskii AV, Goldman IM. N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides, 2001, 22: 979-94.

Can-C™ is for Pets too!